Compare Quest Diagnostics Inc (DGX) vs Garmin Ltd. (GRMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Garmin Ltd. — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Garmin Ltd. trades at $308 (market cap $59.72B). The key difference: Garmin Ltd. is far larger — about 2.3× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| DGX | GRMN | |
|---|---|---|
Market Cap | $26.21B | $59.72B |
Sector | Health | Technology |
52-Week High | $238.50 | $313.16 |
52-Week Low | $173.49 | $187.10 |
Enterprise Value | $31.97B | $57.23B |
Dividend Yield | 1.45% | 1.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Garmin Ltd.
Garmin produces GPS-enabled hardware and software for five verticals: fitness, outdoors, auto, aviation, and marine. The company relies on licensing mapping data to enable its hardware specialized for often niche activities like scuba diving or sailing. Garmin operates in 100 countries and sells its products via distributors as well as relationships with original equipment manufacturers.
Read more on GRMN →
